# SEACOR Marine Holdings Inc.: financial statements, quarterly

SMHI · NYSE · CIK 1690334 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/smhi.md) · [Financials](/companies/smhi/financials.md) · [Filings](/companies/smhi/filings.md) · [Insiders](/companies/smhi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/smhi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [76.9](/filings/0000950170-24-119039.md) | [73.1 d](/filings/0001193125-26-072102.md) | [62.8](/filings/0000950170-25-061098.md) | [69.9](/filings/0000950170-25-100351.md) | [68.9](/filings/0001193125-25-256420.md) | [69.8 d](/filings/0001193125-26-072102.md) | [55.5](/filings/0001690334-26-000008.md) | [60.8](/filings/0001690334-26-000020.md) | [59.2](/filings/0001193125-25-256420.md) | [52.3 d](/filings/0001193125-26-072102.md) | [44.3](/filings/0001690334-26-000008.md) | [54.6](/filings/0001690334-26-000020.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [36.8](/filings/0000950170-24-119039.md) | [29.8 d](/filings/0001193125-26-072102.md) | [14.7](/filings/0000950170-25-061098.md) | [20.3](/filings/0000950170-25-100351.md) | [16.0](/filings/0001193125-25-256420.md) | [23.1 d](/filings/0001193125-26-072102.md) | [13.6](/filings/0001690334-26-000008.md) | [11.3](/filings/0001690334-26-000020.md) | [11.5](/filings/0001193125-25-256420.md) | [9.7 d](/filings/0001193125-26-072102.md) | [6.7](/filings/0001690334-26-000008.md) | [7.9](/filings/0001690334-26-000020.md) |
| Operating income | $m | [9.8](/filings/0000950170-24-119039.md) | [22.6 d](/filings/0001193125-26-072102.md) | [(10.6)](/filings/0000950170-25-061098.md) | [(3.9)](/filings/0000950170-25-100351.md) | [(6.5)](/filings/0001193125-25-256420.md) | [10.6 d](/filings/0001193125-26-072102.md) | [(5.3)](/filings/0001690334-26-000008.md) | [6.1](/filings/0001690334-26-000020.md) | [18.1](/filings/0001193125-25-256420.md) | [(5.2) d](/filings/0001193125-26-072102.md) | [(6.4)](/filings/0001690334-26-000008.md) | [16.0](/filings/0001690334-26-000020.md) |
| Interest expense | $m | [9.5](/filings/0000950170-23-057471.md) | [10.4 d](/filings/0000950170-24-023158.md) | [10.3](/filings/0000950170-24-051298.md) | [10.2](/filings/0000950170-24-088727.md) | [10.1](/filings/0001193125-25-256420.md) | [10.0 d](/filings/0001193125-26-072102.md) | [9.6](/filings/0001690334-26-000008.md) | [8.8](/filings/0001690334-26-000020.md) | [8.9](/filings/0001193125-25-256420.md) | [8.7 d](/filings/0001193125-26-072102.md) | [8.2](/filings/0001690334-26-000008.md) | [8.2](/filings/0001690334-26-000020.md) |
| Income tax | $m | [2.4](/filings/0000950170-24-119039.md) | [6.4 d](/filings/0001193125-26-072102.md) | [0.9](/filings/0000950170-25-061098.md) | [(0.7)](/filings/0000950170-25-100351.md) | [(0.5)](/filings/0001193125-25-256420.md) | [(2.3) d](/filings/0001193125-26-072102.md) | [0.9](/filings/0001690334-26-000008.md) | [2.5](/filings/0001690334-26-000020.md) | [5.4](/filings/0001193125-25-256420.md) | [1.7 d](/filings/0001193125-26-072102.md) | [2.2](/filings/0001690334-26-000008.md) | [4.0](/filings/0001690334-26-000020.md) |
| Net income | $m | [(0.9)](/filings/0000950170-23-057471.md) | [5.7 d](/filings/0000950170-25-027933.md) | [(23.1)](/filings/0000950170-25-061098.md) | [(12.5)](/filings/0000950170-25-100351.md) | [(16.3)](/filings/0001193125-25-256420.md) | [(26.2) d](/filings/0000950170-25-027933.md) | [(15.5)](/filings/0001690334-26-000008.md) | [(6.7)](/filings/0001690334-26-000020.md) | [9.0](/filings/0001193125-25-256420.md) | [(14.6) d](/filings/0001193125-26-072102.md) | [(15.8)](/filings/0001690334-26-000008.md) | [3.3](/filings/0001690334-26-000020.md) |
| Diluted EPS | $ per share | [(0.03)](/filings/0000950170-24-119039.md) | not reported | [(0.84)](/filings/0000950170-25-061098.md) | [(0.45)](/filings/0000950170-25-100351.md) | [(0.59)](/filings/0001193125-25-256420.md) | not reported | [(0.56)](/filings/0001690334-26-000008.md) | [(0.26)](/filings/0001690334-26-000020.md) | [0.35](/filings/0001193125-25-256420.md) | not reported | [(0.61)](/filings/0001690334-26-000008.md) | [0.12](/filings/0001690334-26-000020.md) |
| Basic EPS | $ per share | [(0.03)](/filings/0000950170-24-119039.md) | not reported | [(0.84)](/filings/0000950170-25-061098.md) | [(0.45)](/filings/0000950170-25-100351.md) | [(0.59)](/filings/0001193125-25-256420.md) | not reported | [(0.56)](/filings/0001690334-26-000008.md) | [(0.26)](/filings/0001690334-26-000020.md) | [0.35](/filings/0001193125-25-256420.md) | not reported | [(0.61)](/filings/0001690334-26-000008.md) | [0.13](/filings/0001690334-26-000020.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [55.8](/filings/0000950170-23-057471.md) | [67.5](/filings/0000950170-25-027933.md) | [59.6](/filings/0000950170-24-051298.md) | [40.6](/filings/0000950170-24-088727.md) | [35.6](/filings/0000950170-24-119039.md) | [59.5](/filings/0001193125-26-072102.md) | [43.0](/filings/0000950170-25-061098.md) | [34.4](/filings/0000950170-25-100351.md) | [91.0](/filings/0001193125-25-256420.md) | [68.9](/filings/0001690334-26-000020.md) | [38.7](/filings/0001690334-26-000008.md) | [55.4](/filings/0001690334-26-000020.md) |
| Current assets | $m | [142](/filings/0000950170-23-057471.md) | [165](/filings/0000950170-25-027933.md) | [140](/filings/0000950170-24-051298.md) | [130](/filings/0000950170-24-088727.md) | [131](/filings/0000950170-24-119039.md) | [174](/filings/0001193125-26-072102.md) | [141](/filings/0000950170-25-061098.md) | [133](/filings/0000950170-25-100351.md) | [194](/filings/0001193125-25-256420.md) | [180](/filings/0001690334-26-000020.md) | [172](/filings/0001690334-26-000008.md) | [168](/filings/0001690334-26-000020.md) |
| Total assets | $m | [780](/filings/0000950170-23-057471.md) | [780](/filings/0000950170-25-027933.md) | [745](/filings/0000950170-24-051298.md) | [722](/filings/0000950170-24-088727.md) | [709](/filings/0000950170-24-119039.md) | [727](/filings/0001193125-26-072102.md) | [694](/filings/0000950170-25-061098.md) | [680](/filings/0000950170-25-100351.md) | [692](/filings/0001193125-25-256420.md) | [661](/filings/0001690334-26-000020.md) | [641](/filings/0001690334-26-000008.md) | [633](/filings/0001690334-26-000020.md) |
| Current liabilities | $m | [84.0](/filings/0000950170-23-057471.md) | [77.1](/filings/0000950170-25-027933.md) | [74.4](/filings/0000950170-24-051298.md) | [71.1](/filings/0000950170-24-088727.md) | [80.7](/filings/0000950170-24-119039.md) | [85.0](/filings/0001193125-26-072102.md) | [75.4](/filings/0000950170-25-061098.md) | [81.5](/filings/0000950170-25-100351.md) | [81.2](/filings/0001193125-25-256420.md) | [70.7](/filings/0001690334-26-000020.md) | [72.7](/filings/0001690334-26-000008.md) | [70.8](/filings/0001690334-26-000020.md) |
| Total liabilities | $m | [415](/filings/0000950170-23-057471.md) | [406](/filings/0000950170-25-027933.md) | [396](/filings/0000950170-24-051298.md) | [384](/filings/0000950170-24-088727.md) | [384](/filings/0000950170-24-119039.md) | [429](/filings/0001193125-26-072102.md) | [410](/filings/0000950170-25-061098.md) | [412](/filings/0000950170-25-100351.md) | [415](/filings/0001193125-25-256420.md) | [396](/filings/0001690334-26-000020.md) | [393](/filings/0001690334-26-000008.md) | [381](/filings/0001690334-26-000020.md) |
| Long-term debt | $m | [292](/filings/0000950170-23-057471.md) | [288](/filings/0000950170-25-027933.md) | [282](/filings/0000950170-24-051298.md) | [278](/filings/0000950170-24-088727.md) | [272](/filings/0000950170-24-119039.md) | [317](/filings/0001193125-26-072102.md) | [310](/filings/0000950170-25-061098.md) | [311](/filings/0000950170-25-100351.md) | [312](/filings/0001193125-25-256420.md) | [305](/filings/0001690334-26-000020.md) | [297](/filings/0001690334-26-000008.md) | [290](/filings/0001690334-26-000020.md) |
| Current portion of debt | $m | [28.0](/filings/0000950170-23-057471.md) | [28.4](/filings/0000950170-25-027933.md) | [28.6](/filings/0000950170-24-051298.md) | [28.6](/filings/0000950170-24-088727.md) | [28.6](/filings/0000950170-24-119039.md) | [27.5](/filings/0001193125-26-072102.md) | [30.0](/filings/0000950170-25-061098.md) | [30.0](/filings/0000950170-25-100351.md) | [30.0](/filings/0001193125-25-256420.md) | [30.0](/filings/0001690334-26-000020.md) | [30.4](/filings/0001690334-26-000008.md) | [30.7](/filings/0001690334-26-000020.md) |
| Shareholders' equity | $m | [365](/filings/0000950170-23-057471.md) | [374](/filings/0000950170-25-027933.md) | [349](/filings/0000950170-24-051298.md) | [338](/filings/0000950170-24-088727.md) | [325](/filings/0000950170-24-119039.md) | [298](/filings/0001193125-26-072102.md) | [284](/filings/0000950170-25-061098.md) | [267](/filings/0000950170-25-100351.md) | [277](/filings/0001193125-25-256420.md) | [264](/filings/0001690334-26-000020.md) | [248](/filings/0001690334-26-000008.md) | [252](/filings/0001690334-26-000020.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.1 d](/filings/0000950170-24-119039.md) | [(1.5) d](/filings/0001193125-26-072102.md) | [(7.2)](/filings/0000950170-25-061098.md) | [(12.2) d](/filings/0000950170-25-100351.md) | [0.6 d](/filings/0001193125-25-256420.md) | [8.5 d](/filings/0001193125-26-072102.md) | [(11.5)](/filings/0001690334-26-000008.md) | [(2.1) d](/filings/0001690334-26-000020.md) | [(10.7) d](/filings/0001193125-25-256420.md) | [(12.2) d](/filings/0001193125-26-072102.md) | [(15.1)](/filings/0001690334-26-000008.md) | [(13.2) d](/filings/0001690334-26-000020.md) |
| Capital expenditure | $m | [6.5 d](/filings/0000950170-24-119039.md) | [3.6 d](/filings/0001193125-26-072102.md) | [3.4](/filings/0000950170-25-061098.md) | [0.7 d](/filings/0000950170-25-100351.md) | [0.2 d](/filings/0001193125-25-256420.md) | [3.0 d](/filings/0001193125-26-072102.md) | [20.8](/filings/0001690334-26-000008.md) | [10.2 d](/filings/0001690334-26-000020.md) | [9.3 d](/filings/0001193125-25-256420.md) | [8.4 d](/filings/0001193125-26-072102.md) | [6.1](/filings/0001690334-26-000008.md) | [6.4 d](/filings/0001690334-26-000020.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001193125-25-256420.md) | [0.0 d](/filings/0001193125-26-072102.md) | not reported | not reported | [0.0 d](/filings/0001193125-25-256420.md) | [0.0 d](/filings/0001193125-26-072102.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [26.7](/filings/0000950170-23-057471.md) | [26.8](/filings/0000950170-24-051298.md) | [27.1](/filings/0000950170-24-088727.md) | [27.2](/filings/0000950170-24-119039.md) | [27.3](/filings/0000950170-25-061098.md) | [27.7](/filings/0000950170-25-100351.md) | [27.8](/filings/0001193125-25-256420.md) | [27.9](/filings/0001690334-26-000008.md) | [25.7](/filings/0001690334-26-000020.md) | [25.9](/filings/0001193125-25-256420.md) | [25.8](/filings/0001690334-26-000008.md) | [26.4](/filings/0001690334-26-000020.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 27,132,826 at 2026-07-24, from the cover of the [10-Q filed 2026-07-29](/filings/0001690334-26-000020.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.